Skip to main content
SpringerLink
Log in
Book cover

Inborn Metabolic Diseases pp 86–101Cite as

The Glycogen-Storage Diseases

  • Chapter

Abstract

The glycogen-storage diseases (GSDs) are caused by enzyme defects of glycogen degradation. Some enzyme defects are mainly localized in the liver. Hepatomegaly and hypoglycemia are the main abnormalities. Some enzyme defects are localized in the muscles. Muscle cramps during exertion, progressive weakness and other features of myopathy are predominant. Other enzyme defects are generalized, and they present with variable symptoms related to the organs that are most seriously involved. GSDs are denoted either by the deficient enzyme or by a type number that reflects the historical sequence of elucidation. The latter presentation is used in this chapter. The main characteristics of each GSD type are summarized in Table 6.1.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Von Gierke E (1929) Hepato-nephro-megalia glykogenika (Glykogenspeicherkrankheit der Leber and Nieren). Beitr Pathol Anat 82: 497–513

    Google Scholar 

  2. Corby DC, Putnam CW, Greene HL (1974) Impaired platelet function in glucose-6-phosphatase deficiency. J Pediatr 85: 71–76

    Article  PubMed  CAS  Google Scholar 

  3. Milla PJ, Atherton DA, Leonard JV, Wolff OH, Lake BD (1978) Disordered intestinal function in glycogen storage disease. J Inherit Metab Dis 1: 155–157

    Article  PubMed  CAS  Google Scholar 

  4. Rother KI, Schwenk WF (1995) Glucose production in glycogen storage disease I is not associated with increased cycling through hepatic glycogen. Am J Physiol 269: E774–778

    PubMed  CAS  Google Scholar 

  5. Fernandes J, Berger R, Smit GPA (1984) Lactate as a cerebral metabolic fuel for glucose-6-phosphatase deficient children. Pediatr Res 18: 335–339

    Article  PubMed  CAS  Google Scholar 

  6. Alaupovic P, Fernandes J (1985) The serum apolipoprotein profile of patients with glucose-6-phosphatase deficiency. Pediatr Res 19: 380–384

    Article  PubMed  CAS  Google Scholar 

  7. Fernandes J, Pikaar NA (1972) Ketosis in hepatic glycogenosis. Arch Dis Child 47: 41–46

    Article  PubMed  CAS  Google Scholar 

  8. Talente GM, Coleman RA, Craig C (1994) Glycogen storage disease in adults. Review. Ann Intern Med 120: 218–226

    PubMed  CAS  Google Scholar 

  9. Labrune P, Trioche P, Duvaltier I et al. (1997) Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature. J Pediatr Gastroenterol Nutrit 24: 276–279

    Article  CAS  Google Scholar 

  10. Chen Y-T, Coleman RA, Scheinman JI et al. (199o) Amelioration of proximal renal tubular dysfunction in type I glycogen storage disease with dietary therapy. N Engl J Med 323: 590–593

    Google Scholar 

  11. Restaino I, Kaplan BS, Stanley C, Baker L (1993) Nephrolithiasis, hypercitraturia, and a distal renal tubular acidification defect in type I glycogen storage disease. J Pediatr 122: 392–396

    Article  PubMed  CAS  Google Scholar 

  12. Lee PJ, Patel JS, Fewtrill M et al. (1995) Bone mineralisation in type I glycogen storage disease. Eur J Pediatr 154: 483–487

    Article  PubMed  CAS  Google Scholar 

  13. Kikuchi M, Hasegawa K, Handa I et al. (1991) Chronic pancreatitis in a child with glycogen storage disease type I. Eur J Pediatr 150: 852–853

    Article  PubMed  CAS  Google Scholar 

  14. Smit GPA (1993) The long-term outcome of patients with glycogen storage disease type Ia. Eur J Pediatr 152: S52–55

    Article  PubMed  Google Scholar 

  15. Lee PJ, Celermajer DS, Robinson J et al. (1994) Hyperlipidaemia does not impair vascular endothelial junction in glycogen storage disease type I a. Atherosclerosis 110: 95–100

    Article  PubMed  CAS  Google Scholar 

  16. Lee PJ, Patel A, Hindmarsch PC et al. (1995) The prevalence of polycystic ovaries in the hepatic glycogen storage diseases: its association with hyperinsulinism. Clin Endocrinol 42: 601–606

    Article  CAS  Google Scholar 

  17. Kishani P, Bengun AR, Chen YT (1996) Pulmonary hypertension in glycogen storage disease Type I a. J Inherit Metab Dis 19: 213–216

    Article  Google Scholar 

  18. Goutieres F, Bourgois M, Trioche P et al. (1997) Moyamoya disease in a child with glycogen storage disease type I a. Neuropediatrics 28: 133–134

    Article  PubMed  CAS  Google Scholar 

  19. Greene HL, Slonim AE, Burr IM, Moran JR (198o) Type I glycogen storage disease: five years of management with nocturnal intragastric feeding. J Pediatr 96 590–595

    Google Scholar 

  20. Chen Y-T, Cornblath M, Sidbury JB (1984) Cornstarch therapy in type I glycogen storage disease. N Engl J Med 31o: 171–175

    Article  Google Scholar 

  21. Chen Y-T, Bazzarre CH, Lee MM, Sidbury JB, Coleman RA (1993) Type I glycogen storage disease: nine years of management with cornstarch. Eur J Pediatr 152: S56–59

    Article  PubMed  Google Scholar 

  22. Hayde M, Widhalm K (1990) Effects of cornstarch treatment in very young children with type I glycogen storage disease. Eur J Pediatr 149: 630–633

    Article  PubMed  CAS  Google Scholar 

  23. Fernandes J (1974) The effect of disaccharides on the hyperlactacidaemia of glucose-6-phosphatase-deficient children. Acta Paediatr Scand 63: 695–698

    Article  PubMed  CAS  Google Scholar 

  24. Fernandes J, Alaupovic P, Wit JM (1989) Gastric drip feeding in patients with glycogen storage disease type I: its effects on growth and plasma lipids and apolipoproteins. Pediatr Res 25: 327–331

    Article  PubMed  CAS  Google Scholar 

  25. Wolsdorf JI, Crigler JF (1997) Cornstarch regimens for nocturnal treatment of young adults with type I glycogen storage disease. Am J Clin Nutr 65a 507–1511

    Google Scholar 

  26. Nuoffer JM, Mullis PE, Wiesmann UN (1997) Treatment with low-dose diasoxide in two growth-retarded prepubertal girsl with glycogen storage disease type I a resulted in catch-up growth. J Inherit Metab Dis 20: 790–798

    Article  PubMed  CAS  Google Scholar 

  27. Wolsdorf JI, Laffel LM, Crigler JF (1997) Metabolic control and renal dysfunction in type I glycogen storage disease. J Inherit Metab Dis 20: 559–568

    Article  Google Scholar 

  28. Levy E, Thibault L, Turgeon J et al. (1993) Beneficial effects of fish-oil supplements on lipids, lipoproteins, and lipoprotein lipase in patients with glycogen storage disease type I. Am J Clin Nutr 57: 922–929

    PubMed  CAS  Google Scholar 

  29. Matern D, Starzl TE, Amaout W et al. (1999) Liver transplantation for glycogen storage diseases types I, III and IV. Eur J Pediatr 158[Suppl. 21: S43–48

    Article  Google Scholar 

  30. Ryan IP, Havel RJ, Laros RK (1994) Three consecutive pregnancies in a patient with glycogen storage disease type I A (von Gierke’s disease). Am J Obstet Gynecol 170: 1687–1691

    PubMed  CAS  Google Scholar 

  31. Lei KJ, Shelly LL, Pan CJ, Sidbury JB, Chou JY (1993) Mutations in the glucose-phosphatase gene that cause glycogen storage disease type Ia. Science 262: 580–583

    Article  PubMed  CAS  Google Scholar 

  32. Veiga-da-Cunha M, Gerin I, van Schaftingen E (woo) How many forms of glycogen storage disease type I? Eur J Pediatr (in press)

    Google Scholar 

  33. Simmons PS, Smithson WA, Gronert GA, Haymond MW (1984) Acute myelogenous leukemia and malignant hyper-thermia in a patient with type Ib glycogen storage disease. J Pediatr 105: 428–431

    Article  PubMed  CAS  Google Scholar 

  34. Kikuchi M, Haginoya K, Miyabayashi S et al. (1990) Secondary amyloidosis in glycogen storage disease type I b. Eur J Pediatr 149: 344–345

    Article  PubMed  CAS  Google Scholar 

  35. Hoover EG, Du Bois JJ, Samples TL et al. (1996) Treatment of chronic enteritis in glycogen storage disease type 1 B with granulocyte colony-stimulating factor. J Pediatr Gastroenterol Nutr 22: 346–350

    Article  PubMed  CAS  Google Scholar 

  36. Veiga-da-Cunha M, Gerin I, Chen Y-T et al. (1998) A gene on chromosome 11823 coding for a putative glucose-6-phosphatase translocase is mutated in glycogen storage disease types 1b and Sc. Am J Hum Genet 63: 976–983

    Article  PubMed  CAS  Google Scholar 

  37. Makos MM, Mc Comb RD, Hart MN, Bennett DR (1987) Alpha-glucosidase deficiency and basilar artery aneurism: report of a sibship. Ann Neurol 22: 629–633

    Article  PubMed  CAS  Google Scholar 

  38. Kroos MA, van der Kraan M, van Diggelen OP et al. (1995) Glycogen storage disease type II: frequency of three common mutant alleles and their associated clinical phenotypes studied in 121 patients. J Med Genet 32: 836–837

    Article  PubMed  CAS  Google Scholar 

  39. Mobarhan S, Pintozzi RL, Damle P, Friedman H (1990) Treatment of acid maltase deficiency with a diet high in branched-chain aminoacids. J Parent Enteral Nutr 14: 210–212

    Article  CAS  Google Scholar 

  40. Kuo WL, Hirschhorn R, Huie ML, Hirschhorn K (1996) Localisation and ordering of acid alpha-glucosidase (GAA) and thymidine kinase ( TKI) by fluorescence in situ hybridization. Hum Genet 97: 404–406

    Article  PubMed  CAS  Google Scholar 

  41. Wokke JHJ, Ausems MGEM, van den Boogaard MJH et al. (1995) Genotype-Phenotype correlation in adult-onset acid maltase deficiency. Ann Neurol 38: 450–454

    Article  PubMed  CAS  Google Scholar 

  42. Hoefsloot LH, van der Ploeg AT, Kroes MA et al. (1990) Adult and infantile glycogenosis type II in one family, explained by allelic diversity. Am J Hum Genet 46: 45–52

    PubMed  CAS  Google Scholar 

  43. Haagsma EB, Smit GPA, Niezen-Koning KE et al. (1997) Type III b glycogen storage disease associated with end-stage cirrhosis and hepatocellular carcinoma. Hepatology 25: 537–540

    Article  PubMed  CAS  Google Scholar 

  44. Coleman RA, Winter HS, Wolf B, Gilchrist JM, Chen Y-T (1992) Glycogen storage disease type III (glycogen debranching enzyme deficiency): correlation of biochemical defects with myopathy and cardiomyopathy. Ann Intern Med 116: 896–900

    PubMed  CAS  Google Scholar 

  45. Moses SW, Wandermann KL, Myroz A, Frydman M (1989) Cardiac involvement in glycogen storage disease type III. Eur J Pediatr 148: 764–766

    Article  PubMed  CAS  Google Scholar 

  46. Cuspidi C, Sampieri L, Peliazoli S et al. (1997) Obstructive hypertrophic cardiomyopathy in Type III glycogen-storage disease. Acta Cardiol 52: 117–123

    PubMed  CAS  Google Scholar 

  47. Cohen J, Friedman M (1979) Renal tubular acidosis associated with type III. glycogenosis. Acta Paediatr Scand 68: 779–782

    PubMed  CAS  Google Scholar 

  48. Ding JH, de Barsy T, Brown BI et al. (1990) Immunoblot analysis of glycogen debranching enzyme in different subtypes of glycogen storage disease type III. J Pediatr 116: 95–100

    Article  PubMed  CAS  Google Scholar 

  49. Gremse DA, Bucavalas JC, Balistreri WF (1990) Efficacy of cornstarch therapy in type III glycogen storage disease. Am J Clin Nutr 52: 671–674

    PubMed  CAS  Google Scholar 

  50. Slonim AE, Coleman RA, Moses SW (1984) Myopathy and growth failure in debrancher enzyme deficiency: improvement with high-protein nocturnal enteral therapy. J Pediatr 105: 906–911

    Article  PubMed  CAS  Google Scholar 

  51. De Parscau L, Gibaud P, Hermier M, Francois R (1989) l’Alimentation intragastrique nocturne continue dans les glycogenoses de type I et III. Pediatrie 41: 97–203

    Google Scholar 

  52. Shen J, Bao Y, Liu HM et al. (1996) Mutations in exon 3 of the glycogen debranching enzyme gene are assiociated with glycogen storage disease type III that is differentially expressed in liver and muscle. J Clin Invest 98: 352–357

    Article  PubMed  CAS  Google Scholar 

  53. Mc Conkie-Rosell A, Wilson C, Piccoli DA et al. (1996) Clinical and laboratory findings in four patients with the non-progressive hepatic form of type IV glycogen storage disease. J Inherit Metab Dis 19: 51–58

    Article  Google Scholar 

  54. Bao Y, Kishumi P, Wu JY, Chen YT (1996) Hepatic and neuromuscular forms of glycogen storage disease type IV caused by mutations in the same glycogen-branching enzyme gene. J Clin Invest 97: 941–948

    Article  PubMed  CAS  Google Scholar 

  55. Servidei S, Riepe RE, Langston C et al. (1987) Severe cardio- 76. pathy in branching enzyme deficiency. J Pediatr 111: 51–56

    Article  PubMed  CAS  Google Scholar 

  56. Selby R, Starzl TE, Yunis E et al. (1993) Liver transplantation for type I and type IV glycogen storage disease. Eur J Pediatr 77. 152: S71 - S76

    Article  Google Scholar 

  57. Starzl TE, Demetris AJ, Trucoo M et al. (1993) Chimerism after liver transplantation for type IV glycogen storage disease and type I Gaucher disease. N Engl J Med 328: 745–749 78.

    Google Scholar 

  58. Maire I, Baussan C, Moatti N, Mathieu M, Lemonnier A (1991) Biochemical diagnosis of hepatic glycogen storage diseases: 20 years French experience. Clin Biochem 24: 169–178.

    Article  PubMed  CAS  Google Scholar 

  59. Madiom M, Besley GTN, Cohen PTW, Marrian VJ (1989) Phosphorylase b kinase deficiency in a boy with glycogenosis affecting both liver and muscle. Eur J Pediatr 14 (9): 52–53

    Google Scholar 

  60. Kagalwalla AF, Yasmeen A, Sulaiman Al Ajaji et al. (1995) Phosphorylase b kinase deficiency glycogenosis with cirrhosis of the liver. J Pediatr 127: 602–605

    Article  PubMed  CAS  Google Scholar 

  61. Sanjad SA, Kaddoura RE, Nazir HM et al. (1993) Fanconi’s syndrome with hepatorenal glycogenosis associated with phosphorylase b kinase deficiency. Am J Dis Child 147: 957–959

    PubMed  CAS  Google Scholar 

  62. Willems PJ, Gerver WJM, Berger R, Fernandes J (1990) The natural history of liver glycogenosis due to phosphorylase kinase deficiency: a longitudinal study of 41 patients. Eur J Pediatr 149: 268–271

    Article  PubMed  CAS  Google Scholar 

  63. Hendrickx J, Dams E, Couche P et al. (1996a) X-linked liver glycogenosis type II (XLG II) is caused by mutations in PHKA2, the gene encoding the liver a subunit of phosphorylase kinase. Hum Mol Genet 5: 649–652

    Article  PubMed  CAS  Google Scholar 

  64. Nakai A, Shigematsu Y, Takano T et al. (1994) Uncooked 84. starch treatment for hepatic phosphorylase kinase deficiency. Eur J Pediatr 153: 581–583

    Article  PubMed  CAS  Google Scholar 

  65. Smit GPA, Fernandes J, Leonard JV et al. (1990) The longterm outcome of patients with glycogen storage diseases. 85. J Inherit Metab Dis 13: 411–418

    Article  PubMed  CAS  Google Scholar 

  66. Hendrickx J, Willems PJ (1996b) Genetic deficiencies of the glycogen phosphorylase system. Hum Genet 97: 551–556

    Google Scholar 

  67. Burwinkel B, Bakker HD, Herschkovitz E et al. (1998) Mutations in the liver glycogen phosphorylase gene (PYGL) underlying glycogenosis type VI ( Hers disease ). Am J Hum Genet 62: 785–791

    Google Scholar 

  68. Van de Berg IET, van Beurden EACM, Malingre HEM et al. (1995) X-linked liver phosphorylase deficiency associated with mutations in the human liver phosphorylase kinase a subunit. Am J Hum Genet 56: 381–387 88.

    Google Scholar 

  69. Burwinkel B, Maichelle AJ, Aagenaes O et al. (1997) Autosomal glycogenosis of liver and muscle due to phosphorylase kinase deficiency is caused by mutations in the 89. phosphorylase kinase ß subunit ( PHKB ). Hum Mol Genet 6: 1109–1115

    Google Scholar 

  70. Servidei S, DiMauro S (1989) Disorders of glycogen metabolism of muscle. Neurol Clin 7: 159–178

    PubMed  CAS  Google Scholar 

  71. Abarbanel JM, Bashan N, Potashnik R et al. (1986) Adult 91. muscle phosphorylase “b” kinase deficiency. Neurology 86: 560–562

    Article  Google Scholar 

  72. Servidei S, Metlay LA, Chodosh J, Di Mauro S (1988) Fatal infantile cardiopathy caused by phosphorylase b kinase 92. deficiency. J Pediatr 113: 82–85

    Article  PubMed  CAS  Google Scholar 

  73. Fox IH, Palella TD, Kelley WN (1987) Hyperuricemia: a marker for cell energy crisis. N Engl J Med 317: 111–112

    Article  PubMed  CAS  Google Scholar 

  74. Mineo I, Kono N, Hara N et al. (1987) Myogenic hyperuricemia. A common pathophysiologic feature of glyco 93. genosis types III, V and VII. N Engl J Med 317: 75–80

    Article  PubMed  CAS  Google Scholar 

  75. Slonim AE, Goans PJ (1985) Myopathy in Mc Ardle’s syndrome. Improvement with a high-protein diet. N Engl J Med 312: 355–359

    Article  PubMed  CAS  Google Scholar 

  76. Haller RG, Lewis SF (1991) Glucose-induced exertional fatigue in muscle phosphofructokinase deficiency. N Engl J Med 324: 364–369

    Article  PubMed  CAS  Google Scholar 

  77. Yang BZ, Ding JH, Enghild JJ, Bao Y, Chen YT (1992) Molecular cloning and nucleotide sequence of cDNA encoding human muscle glycogen debranching enzyme. J Biol Chem 267: 9294–9299

    PubMed  CAS  Google Scholar 

  78. El-Schahawi M, Tsujino S, Shanske S, di Mauro S (1996) Diagnosis of Mc Ardle’s disease by molecular genetic analysis of blood. Neurology 47: 579–580

    Article  PubMed  CAS  Google Scholar 

  79. Vosgerd M, Kubisch C, Burwinkel B et al. (1998) Mutation analysis in myophosphorylase deficiency ( Mc Ardle’ disease ). Ann Neurol 43: 326–331

    Article  Google Scholar 

  80. Wilkinson DA, Tonin P, Shanske S et al. (1994) Clinical and biochemical features of to adult patients with muscle phosphorylase kinase deficiency. Neurol 44: 461–466

    Article  CAS  Google Scholar 

  81. Wehner M, Clemens PR, Engel AG, Kilimann (1994) Human muscle glycogenosis due to phosphorylase kinase deficiency associated with a nonsense mutation in the muscle isoform of the a subunit. Hum Mol Genet 3: 1983–1987

    Article  PubMed  CAS  Google Scholar 

  82. Sugie H, Kobayashi J, Sugie Y et al. (1988) Infantile muscle glycogen storage disease: phosphoglucomutase deficiency with decreased muscle and serum carnitine levels. Neurology 38: 602–605

    Article  PubMed  CAS  Google Scholar 

  83. Whitehouse DB, Putt W, Lovegrove JU et al. (1992) Phosphoglucomutase s: complete human and rabbit mRNA sequencies and direct mapping of this highly polymorphic marker on human chromosome 1. Proc Nail Acad Sci USA 89: 411–415

    Article  CAS  Google Scholar 

  84. Vissing J, Galbo H, Haller RG (1996) Paradoxically enhanced glucose production during exercise in humans with blocked glycolysis caused by muscle phosphofructokinase deficiency. Neurology 47: 766–771

    Article  PubMed  CAS  Google Scholar 

  85. Servidei S, Bonilla E, Diedrich RG et al. (1986) Fatal infantile form of muscle phosphofructokinase deficiency. Neurology 36: 1465–1470

    Article  PubMed  CAS  Google Scholar 

  86. Howard TD, Akots G, Bowden DW (1996) Physical and genetic mapping of the muscle phosphofructokinase gene (PFKM): reassignment to human chromosome 12q. Genomics 34: 122–127

    Article  PubMed  CAS  Google Scholar 

  87. Tonin P, Shanske S, Miranda AF et al. (1993) Phosphoglycerate kinase deficiency: biochemical and molecular genetic studies in a new myopathic variant. ( PGK Alberta ). Neurology 43: 387–391

    Article  PubMed  CAS  Google Scholar 

  88. Tsujino S, Shanske S, Sakoda S et al. (1993) The molecular genetic basis of muscle phosphoglycerate mutase ( PGAM) deficiency. Am J Hum Genet 52: 472–477

    PubMed  CAS  Google Scholar 

  89. Kanno T, Sudo K, Takuchi I et al. (1980) Hereditary deficency of lactate dehydrogenase M-subunit. Clin Chim Acta 108: 267

    Article  PubMed  CAS  Google Scholar 

  90. Gitzelmann R, Spycher MA, Fiel G et al. (1996) Liver glycogen synthase deficiency: a rarely diagnosed entity. Eur J Pediatr 155: 561–567

    Article  PubMed  CAS  Google Scholar 

  91. Byrne BM, Killmer MD, Turner RC, Aynsley-Green A (1995) Glucose homoiostasis in adulthood and in pregnancy in a patient with hepatic glycogen synthase deficiency. Br J Obstet Gynaecol 102: 931–933

    Article  PubMed  CAS  Google Scholar 

  92. Santer R, Schneppenheim R, Dombrowski A et al. (1997) Mutations in GLUT 2, the gene for the liver-type glucose transporter in patients with Fanconi-Bickel syndrome. Nature Genet 17: 324–326 (published erratum in Nature Genet 18:298, 1998)

    Article  PubMed  CAS  Google Scholar 

  93. Santer R, Schneppenheim R, Suter D, Schaub J, Steinmann B (1998) Fanconi-Bickel syndrome - the original patient and his natural history, historical steps leading to the primary defect, and a review of the literature. Review. Eur J Pediatr 157: 783–797

    CAS  Google Scholar 

Download references

Authors
  1. J. Fernandes
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. P. A. Smit
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Veldweg 87, 8051 NP, Hattem, The Netherlands

    John Fernandes (Professor Emeritus of Pediatrics) (Professor Emeritus of Pediatrics)

  2. Hospital Necker-Enfants Malades, 149 Rue de Sevres, 75743, Paris Cedex 15, France

    Jean-Marie Saudubray

  3. Institute of Cellular Pathology, Université Catholique de Louvain, Avenue Hippocrate 75, 1200, Brussels, Belgium

    Georges Van den Berghe (Christian de Duve) (Christian de Duve)

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Fernandes, J., Smit, G.P.A. (2000). The Glycogen-Storage Diseases. In: Fernandes, J., Saudubray, JM., Van den Berghe, G. (eds) Inborn Metabolic Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-04285-4_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-04285-4_6

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-04287-8

  • Online ISBN: 978-3-662-04285-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation